Prognostic factors affecting locoregional recurrence in patients with stage IIIB noninflammatory breast cancer

World Journal of Surgery

Volumn 31, Issue 9, 2007, Pages 1724-1730

  Gülben, Kaptan ^a   Berberoǧlu, Uǧur ^a   Cengiz, Aziz ^a   Altinyollar, Hüseyin ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; PROTEIN P53; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; DISEASE CONTROL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH VESSEL; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; MENOPAUSE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BREAST NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548046953     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9139-7     Document Type: Article

References (40)

1. Heys SD, Eremin JM, Sarkar TK, et al. (1994) Role of multimodality therapy in the management of locally advanced carcinoma of the breast. J Am Coll Surg 179:493-504
2. Wolff AC, Davidson NE (2002) Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease. Oncologist 7:239-245
3. Low JA, Berman AW, Steinberg SM, et al. (2004) Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 22:4067-4074
4. Hunt KK, Ames FC, Singletary SE, et al. (1996) Locally advanced noninflammatory breast cancer. Surg Clin North Am 76:393-410
5. Bonadonna G, Veronesi U, Brambilla C, et al. (1990) Primary chemotherapy to avoid mastectomy in tumours with diameters of three centimeters or more. J Natl Cancer Inst 82:1539-1545
6. Hortobagyi GN, Buzdar AU, Strom EA, et al. (1995) Primary chemotherapy for early and advanced breast cancer. Cancer Lett 90:103-109
7. Buzdar AU, Singletary SE, Booser DJ, et al. (1995) Combined modality treatment of stage III and inflammatory breast cancer. Surg Oncol Clin North Am 4:715-734
8. Wallgren A, Bonetti M, Gelber RD, et al. (2003) Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group trials I through VII. J Clin Oncol 21:1205-1213
9. Voogd AC, Nielsen M, Peterse JL, et al. (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19:1688-1697
10. Woodward WA, Strom EA, Tucker SL, et al. (2003) Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57:336-344
11. Aktepe F, Kapucuoǧlu N, Pak I (1996) The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology 29:63-67
12. Greene FL, Page DL, Fleming ID, et al. (2002) AJCC Cancer Staging Manual, 6th Edition, New York, Springer-Verlag, 227-228
13. Frierson HF, Walber RA, Berean KW, et al. (1995) Interobserver reproducibility of the Notthingam Modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195-198
14. Eltahir A, Heys SD, Hutcheon AW, et al. (1998) Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg 175:127-132
15. Sataloff DM, Mason BA, Prestipino AJ, et al. (1995) Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 180:297-306
16. Bergh J, Jonsson PE, Glimelius B, et al. (2001) A systematic overview of chemotherapy effects in breast cancer. Acta Oncol 40:253-281
17. YIldIrIm E, Semerci E, Berberoǧlu U (2000) The analysis of prognostic factors in stage III-B non-inflammatory breast cancer. Eur J Surg Oncol 26:34-38
18. Swain SM (1990) Selection therapy for sage III breast cancer. Surg Clin North Am 70:1061-1080
19. Hutcheon AW, Heys SD, Miller ID, et al. (2001) Improvements in survival in patients receiving primary chemotherapy with docetaxel for breast cancer: a randomized controlled trial. Breast Cancer Res Treat 69:298
20. Grohn P, Heinonen E, Klefstrom P, et al. (1984) Adjuvant postoperative radiotherapy, chemotherapy and immunotherapy in stage III breast cancer. Cancer 54:670-674
21. Hortobagyi GN, Ames FC, Buzdar AK, et al. (1988) Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 62:2507-2516
22. Schwartz G, Birchansky C, Komarnicky L, et al. (1994) Induction chemotherapy followed by breast conservation for locally advanced carcinoma of breast. Cancer 73:362-369
23. Fisher B, Bryant J, Wolmark N, et al. (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685
24. Braud AC, Asselain B, Scholl S, et al. (1999) Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse? Eur J Cancer 35:392-397
25. Brain E, Garrino C, Misset JL, et al. (1997) Long term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. Br J Cancer 75:1360-1367
26. Fisher B, Brown A, Mamounas E, et al. (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483-2493
27. Bear HD, Anderson S, Brown A, et al. (2003) The effect on tumor response of adding preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21:4165-4174
28. Jatoi I, Michael AP (2005) Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer. A pooled analysis of updated results. Am J Clin Oncol 28:289-294
29. Jacquillat C, Weil M, Baillet F, et al. (1990) Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 66:119-129
30. Buchholz TA, Tucker SL, Masullo L, et al. (2002) Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20:17-23
31. Rustogi A, Budrukkar A, Dinshaw K, et al. (2005) Management of locally advanced breast cancer: Evolution and current practice. J Cancer Res Ther 1:21-30
32. Fisher B, Anderson S, Fisher ER, et al. (1991) Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 338:327-331
33. Veronesi U, Marubini E, Del Vecchio M, et al. (1995) Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87:19-27
34. McIntosh SA, Ogston KN, Payne S, et al. (2003) Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg 185:525-531
35. Huang EH, Tucker SL, Strom EA, et al. (2005) Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62:351-357
36. Commiskey RD, Mera R, Levince EA (1998) Preoperative chemotherapy for locally advanced breast carcinoma at Charity Hospital, New Orleans, Lousiana. Am Surg 64:103-106
37. Fentiman IS, Lavelle MA, Caplan D, et al. (1986) The significance of supraclavicular fossa node recurrence after radical mastectomy. Cancer 57:908-910
38. Rubens RD, Bartelink H, Engelsman E, et al. (1989) Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. Eur J Cancer Clin Oncol 25:667-678
39. Swain SM, Sorace RA, Bagley CS, et al. (1987) Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47:3889-3894
40. Loprinzi C, Carbone P, Tormey D, et al. (1984) Aggressive combined modality therapy for advanced local-regional breast carcinoma. J Clin Oncol 2:157-163